Companies · Other Health Care

Trendlines Group Ltd.

M.P. MISGAV · Other Health Care

Diligence memoA one-page analyst read on Trendlines Group Ltd. — recommendation, valuation, rhythm, risks.
$18.5M
Total raised · real
5
Rounds
0.6×
Latest step-up
Top 18%
Sector rank · raised
Series A
Latest stage · inferred · Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Trendlines Group Ltd. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.07× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
Active
  • Last raise 9 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Trendlines Group Ltd. is one of 5376 Other Health Care companies tracked from M.P. MISGAV. By capital raised it ranks in the upper tier (ahead of 83% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2
Investors (latest)
2025-09-23
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2014-04-30 Raised $1.3M (real) Modeled valuation $33M (est)$1.3M$33MSeed2014Seed · 2014-04-30 Raised $1.3M (real) Modeled valuation $33M (est)$1.3M$33MSeed2014Seed · 2015-02-22 Raised $1.3M (real) Modeled valuation $31M (est)$1.3M$31MSeed2015Series A · 2022-03-11 Raised $15M (real) Modeled valuation $165M (est)$15M$165MSeries A2022Series A · 2024-11-06 Raised $585K (real) Modeled valuation $2.5M (est)$585K$2.5MSeries A2024Series A · 2025-09-23 Raised $377K (real) Modeled valuation $1.2M (est)$377K$1.2MSeries A2025+$1.3M+$1.3M+$15M+$585K+$377KCumulative $20M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.3M · 2014
Seed extension$1.3M · 2014
Seed extension$1.3M · 2015
Series A$15.0M · 2022
Series A extension$585K · 2024
Series A extension$377K · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$1.2M
Base estimate est.
$484K
Conservative case
$1.9M
Upside case
$1.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $32.7M · 2014-04-302014Seed · modeled $32.7M · 2014-04-30Seed · modeled $31.3M · 2015-02-22Series A · modeled $165.0M · 2022-03-11Series A · modeled $2.5M · 2024-11-06Series A · modeled $1.2M · 2025-09-232025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
0.8 yr
Elapsed time used
0.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
27 mo
Avg between rounds
$1.6M/yr
Capital velocity
12.2 yr
On record since
2014
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.6× above median
This company$18.5M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.1× of median
This company$377K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$1.2M
Sector median$22.1M

Raised more than 83% of sector peers (real $). Modeled value above 7% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #77 of 83.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)HelloJoy, Inc. · Series A Raised $26.3M · modeled $55.0M (est)Maui Imaging, Inc. · Series A Raised $29.9M · modeled $51.0M (est)Celltrio, Inc. · Series A Raised $15.0M · modeled $50.8M (est)Medmo, Inc. · Series A Raised $31.7M · modeled $44.7M (est)Vertical Orthopaedics, Inc. · Series A Raised $16.7M · modeled $44.0M (est)AbriCare, Inc. · Series A Raised $15.0M · modeled $39.1M (est)WP Stillwater, LLC · Series A Raised $14.3M · modeled $38.1M (est)Sylke, Inc. · Series A Raised $15.9M · modeled $37.6M (est)Iridex Corp · Series A Raised $10.0M · modeled $37.2M (est)2GHealth Inc. · Series A Raised $17.5M · modeled $35.6M (est)Okc Alf 4, Llc · Series A Raised $8.9M · modeled $34.5M (est)HC Jones, Inc. · Series A Raised $14.1M · modeled $33.4M (est)Trendlines Group Ltd. (this company) Raised $18.5M · modeled $1.2M (est)Trendlines Group Ltd.
CompanyStageRaised · realValue · estvs peer med.
HelloJoy, Inc.Series A$26.3M$55.0M3.37×
Maui Imaging, Inc.Series A$29.9M$51.0M3.12×
Celltrio, Inc.Series A$15.0M$50.8M3.11×
Medmo, Inc.Series A$31.7M$44.7M2.74×
Vertical Orthopaedics, Inc.Series A$16.7M$44.0M2.69×
AbriCare, Inc.Series A$15.0M$39.1M2.39×
WP Stillwater, LLCSeries A$14.3M$38.1M2.33×
Sylke, Inc.Series A$15.9M$37.6M2.30×
Iridex CorpSeries A$10.0M$37.2M2.28×
2GHealth Inc.Series A$17.5M$35.6M2.18×
Okc Alf 4, LlcSeries A$8.9M$34.5M2.11×
HC Jones, Inc.Series A$14.1M$33.4M2.04×
Trendlines Group Ltd. this companySeries A$18.5M$1.2M0.07×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.3M2014-04-30$6.6M$32.7M85%
Seed$1.3M2014-04-30$6.6M$32.7M85%
Seed$1.3M2015-02-22$6.3M$31.3M85%
Series A$15.0M2022-03-11$68.2M$165.0M90%
Series A$585K2024-11-06$2.7M$2.5M90%
Series A$377K2025-09-23$1.7M$1.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.3M2014-04-30
    • First recorded raise — entered as Seed.
    • 17 investors on this round.
  2. Seed$1.3M2014-04-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 17 investors on this round.
  3. Seed$1.3M2015-02-22
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 19 investors on this round.
  4. Series A$15.0M2022-03-11
    • Raised again after 85 mo — slower than the ~14 mo sector norm.
    • Round 11.9× larger than the prior — scaling up.
    • 3 investors on this round.
  5. Series A$585K2024-11-06
    • Raised again after 32 mo — slower than the ~14 mo sector norm.
    • Round 25.6× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  6. Series A$377K2025-09-23
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 2 investors on this round.
Intelligence
2028 ~Q1
Modeled next raise · ~27mo cadence
$377K
Modeled next size est.range $377K$604K
0.6×
Last step-up
$1.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Elka Nir1 other2022-03
Steve Rhodes1 other2022-03
Zeev Bronfeld1 other2022-03
Boon Ann Sin2022-03
David Todd Dollinger2014-04
Gabi Todd Heller2014-04
Gabriela David Heller2015-02
Haim Brosh2022-03
Hang Chang Chieh2022-03
Igor Teck Vatenmacher2025-09
Low Teck Seng2024-11
Nehama Ronen2024-11
Sarit Teck Zeevi2024-11
Stephen Chang Haslett2022-03
Stephen Louis Rhodes2015-02
Steve Todd Rhodes2014-04
Todd David Dollinger2015-02
Todd Dollinger2022-03
Yosef David Hazan2015-02
Yosef David Ron2015-02
Yossi Todd Hassan2014-04
Yossi Todd Ron2014-04
Zeev David Bronfeld2015-02
Zeev Todd Bronfeld2014-04
Registry & provenance

Trendlines Group Ltd. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1607852
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Rimidi, Inc.Other Health CareSeries A$18.2M$1.4Msame sector · same stage
OurPharma Holdings LLCOther Health CareSeries A$15.9M$824Ksame sector · same stage
South Campus Surgery Center LlcOther Health CareSeries A$15.3M$1.8Msame sector · same stage
Wellist, Inc.Other Health CareSeries A$12.8M$1.3Msame sector · same stage
Entera Bio Ltd.BiotechnologySeries A$22.2M$44.8Mnetwork1 shared operator · same stage
Mitesco, Inc.Other Health CareSeries A$29.6M$394Ksame sector · same stage
Theravida, Inc.Other Health CareSeries A$9.1M$1.6Msame sector · same stage
Inspire Veterinary Partners, Inc.Other Health CareSeries A$8.9M$1.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Strataca GroupOther Health CareSeries A$211.9M82%
BridgepointMD, Inc.Other Health CareSeed$12.8M81%
BaseHealth, Inc.Other Health CareSeries A$91.7M81%
ImmuneTarget, Inc.Other Health CarePre-Seed$18.7M80%
Smile Source Holdings, L.P.Other Health CareSeries B$308.7M80%
True Medicine Inc.Other Health CareSeries B$175.7M80%
Ridgeline Utah LLCOther Health CareSeries A$103.2M80%
PathwaysGI, Inc.Other Health CarePre-Seed$2.9M80%
Frequently asked
How much funding has Trendlines Group Ltd. raised?
Trendlines Group Ltd. has raised approximately $18.5M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Trendlines Group Ltd.'s estimated valuation?
Provath's modeled valuation for Trendlines Group Ltd. is approximately $1.2M (modeled range $484K–$1.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Trendlines Group Ltd. at?
Trendlines Group Ltd.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Sep 23.
What does Trendlines Group Ltd. do and where is it based?
Trendlines Group Ltd. operates in the Other Health Care sector, based in M.P. MISGAV.
Explore related

See where Trendlines Group Ltd. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Trendlines Group Ltd., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.